Literature DB >> 30190985

Nonsurgical multidisciplinary approach for recurrent hepatocellular carcinoma after surgical resection.

Kang Mo Kim.   

Abstract

Hepatocellular carcinoma (HCC) is characterized by frequent recurrence, even after curative resection and local ablation, and this represents a major challenge for HCC treatment. Although several treatment guidelines have been reported, they detail initial treatment choices and there are no established guidelines for recurrent HCC. The current treatment options for recurrent HCC do not differ from the primary treatments, but the unique characteristics of HCC recurrence should be considered when choosing treatments and each treatment should be individualized to different clinical situations. Furthermore, combinations of various treatments have been recently attempted. This review summarizes the current evidence for nonsurgical treatments of recurrent HCC after resection and suggests a multidisciplinary approach to improving the prognosis of recurrent HCC.

Entities:  

Keywords:  drug-eluting bead transarterial chemoembolization; hepatocellular carcinoma; multidisciplinary approach; radiation therapy; radiofrequency ablation; re-resection; salvage liver transplantation; sorafenib; transarterial chemoembolization; transarterial radioembolization

Year:  2015        PMID: 30190985      PMCID: PMC6095416          DOI: 10.2217/hep.14.31

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN: 2045-0923


  44 in total

Review 1.  Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

Authors:  J-L Raoul; B Sangro; A Forner; V Mazzaferro; F Piscaglia; L Bolondi; R Lencioni
Journal:  Cancer Treat Rev       Date:  2010-08-17       Impact factor: 12.111

Review 2.  Current strategy for staging and treatment: the BCLC update and future prospects.

Authors:  Alejandro Forner; María E Reig; Carlos Rodriguez de Lope; Jordi Bruix
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

3.  Clinical management of recurrent hepatocellular carcinoma.

Authors:  P H Lee; W J Lin; Y M Tsang; R H Hu; J C Sheu; M Y Lai; H C Hsu; W May; C S Lee
Journal:  Ann Surg       Date:  1995-11       Impact factor: 12.969

4.  Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

Authors:  Masatoshi Kudo; Namiki Izumi; Norihiro Kokudo; Osamu Matsui; Michiie Sakamoto; Osamu Nakashima; Masamichi Kojiro; Masatoshi Makuuchi
Journal:  Dig Dis       Date:  2011-08-09       Impact factor: 2.404

5.  Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.

Authors:  Sang Min Yoon; Young-Suk Lim; Hyung Jin Won; Jong Hoon Kim; Kang Mo Kim; Han Chu Lee; Young-Hwa Chung; Yung Sang Lee; Sung Gyu Lee; Jin-Hong Park; Dong Jin Suh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-27       Impact factor: 7.038

Review 6.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

7.  Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors.

Authors:  Dongil Choi; Hyo K Lim; Hyunchul Rhim; Young-sun Kim; Byung Chul Yoo; Seung Woon Paik; Jae-Won Joh; Cheol Keun Park
Journal:  Ann Surg Oncol       Date:  2007-05-24       Impact factor: 5.344

8.  Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.

Authors:  Ju Hyun Shim; Kang Mo Kim; Young-Joo Lee; Gi-Young Ko; Hyun-Ki Yoon; Kyu-Bo Sung; Kwang-Min Park; Sung-Gyu Lee; Young-Suk Lim; Han Chu Lee; Young-Hwa Chung; Yung Sang Lee; Dong Jin Suh
Journal:  Ann Surg Oncol       Date:  2009-12-22       Impact factor: 5.344

9.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

10.  Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Authors:  Johannes Lammer; Katarina Malagari; Thomas Vogl; Frank Pilleul; Alban Denys; Anthony Watkinson; Michael Pitton; Geraldine Sergent; Thomas Pfammatter; Sylvain Terraz; Yves Benhamou; Yves Avajon; Thomas Gruenberger; Maria Pomoni; Herbert Langenberger; Marcus Schuchmann; Jerome Dumortier; Christian Mueller; Patrick Chevallier; Riccardo Lencioni
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-12       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.